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ABSTRACT: A second generation of chiral bicyclic dehydroalanines easily
accessible from serine has been developed. These scaﬀolds behaved as
excellent S-Michael acceptors when tri-O-acetyl-2-acetamido-2-deoxy-1-thio-α-
D-galactopyranose (abbreviated as GalNAc-α-SH) was used as a nucleophile.
This addition proceeds with total chemo- and stereoselectivity, complete atom
economy, quickly, and at room temperature, making it a true click reaction.
The Michael adducts were easily transformed into S-(2-acetamido-2-deoxy-α-
D-galactopyranosyl)-L- and -D-cysteines, which can be regarded as mimics of
the Tn antigen derived from L-Ser (α-D-GalNAc-L-Ser) and D-Ser (α-D-
GalNAc-D-Ser), respectively.
The ﬁnding of the Tn antigen (α-D-GalNAc-L-Ser/Thr) andits unusual expression associated with tumor growth is
considered an innovative point in the glycobiology ﬁeld.1a In the
past decade, considerable eﬀorts have been made toward the
development of antitumor vaccines based on this simple
structure.1 However, no cancer vaccines of this type have
reached the clinic to date.2a This might be due to the sensitivity of
these antigens to endogenous glycosidases, which decreases in
vivo bioavailability.2b,c Accordingly, several mimics of the Tn
antigen based on diverse structural modiﬁcations have been
proposed to improve immunogenicity of cancer vaccines.3 These
approaches involved the preparation of modiﬁed mucin-like
glycopeptides4−7 or conformationally restricted Tn antigen
mimics.8 Additionally, Tn antigen mimics based on cysteine S-
glycosylation have been used.6b,9 Very recently, we have
described that sulfa-Tn peptides are recognized by monoclonal
anti-MUC1 antibodies.10 Since the discovery of cysteine S-
glycosylation11 as a new post-translational modiﬁcation
(PTM),12,13 several S-glycosylation methods have been
developed.11,14 These methods use protected carbohydrates as
electrophiles and Cys derivatives as nucleophiles and have been
applied to the synthesis of β-S-glycosyl amino acids and β-S-
glycopeptides.15,16 Conversely, the formation of the α-S-
glycosidic bond,15c especially involving the α-S-GalNAc moiety
present in the sulfa-Tn antigen 1,16,17 has received less attention
(Scheme 1). α-Thio-linked glycosyl amino acids have been
obtained by condensation of a β-bromoalanine derivative with
the corresponding thiolate salt of the carbohydrate.17 On the
other hand, dehydroalanine (Dha)18−20 is an unsaturated amino
acid of both biological and synthetic interest18 used as chemical
precursor to a range of site-selective PTM by the conjugate
addition of thiols.20 For instance, thiols with large alkyl chains or
ﬂuorescent groups, cysteine derivatives, and thioacetate are
examples of nucleophiles used to install PTM on peptides by this
method. Moreover, Dha-containing peptides have been used as
S-Michael acceptors for nucleophilic thiocarbohydrates,
although with low diastereoselectivities.21,22 Motivated by the
absence of highly stereocontrolled procedures for the selective
formation of α-S-glycosidic bonds from dehydroamino acids, we
recently reported the inexpensive synthesis of a new chiral Dha
derivative derived from serine (2) on a multigram scale.23a This
substrate was used in stereoselective S-Michael additions of
appropriately protected thiocarbohydrates such as tri-O-acetyl-2-
acetamido-2-deoxy-1-thio-α-D-galactopyranose (3, abbreviated
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Scheme 1. Retrosynthesis of Sulfa-Tn Antigen from Chiral
Dha Derivatives
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as GalNAc-α-SH), with generally high yields and diastereose-
lectivities (Scheme 1).23b This procedure has been applied to the
synthesis of S-(2-acetamido-2-deoxy-α-D-galactopyranosyl)-L-
cysteine 1, which is regarded as a mimic of Tn antigen named
sulfa-Tn antigen.
The key S-Michael addition step from Dha 2 and GalNAc-α-
SH 3 proceeded with a moderate yield (67%).24 Moreover, in
order to obtain a high diastereoselectivity, an organic base (1,8-
diazabicycloundec-7-ene, DBU) and cryogenic temperatures (dr
>95:5 at −78 °C, dr = 41:59 at 25 °C) were required, which
might limit the scope of this transformation under milder and/or
biocompatible conditions.
Once the role of the tertiary alcohol at the oxazolidin-2-one
ring as a stereodirecting group in the S-Michael addition was
discarded (Supporting Information), we envisioned that intra-
molecular lactonization of this alcohol with the methyl acrylate
group would signiﬁcantly reduce the conformational ﬂexibility of
2, potentially conferring more robust diastereoinducing proper-
ties to our chiral scaﬀold. Simultaneously, the formation of a
fused oxazolidin-5-one ring could facilitate the ﬁnal deprotection
and/or activate the C-terminus of the resulting bicyclic
dehydroamino acid (4), enabling facile peptide coupling
reactions at this position (Scheme 1).
Thus, the new bicyclic Dha scaﬀold 4 was readily synthesized,
on a gram scale, in two steps by basic hydrolysis of the methyl
ester group of 2 followed by lactonization using 1-ethyl-3-(3-
(dimethylamino)propyl)carbodiimide (EDCI) as a coupling
reagent in the presence of 4-(dimethylamino)pyridine (DMAP)
as a base. The same procedure was applied to the corresponding
enantiomer ent-4 starting from D-Ser (Scheme 1). The
diastereomeric purity and stereochemistry of both substrates
was maintained upon lactonization, as veriﬁed crystallographi-
cally (Supporting Information).
Both chiral Dha derivatives 4 and ent-4 showed excellent
Michael acceptor properties, cleanly reacting with GalNAc-α-SH
3 with DBU as a base, under the same conditions reported23b for
Dha derivative 2. After 3 h of reaction in THF at −78 °C, adduct
5 or 5′ was obtained as a single diastereomer (dr > 95:5) in high
yields (86−98%, Supporting Information). The absolute
conﬁguration of the new stereocenter of compounds 5 and 5′
created in the 1,4-conjugate addition was determined by
NOESY−NMR experiments. In both cases, the observation of
a medium-size NOE cross-peak between the hydrogens of the
−CH2S− substituent at the C3 and the CH3 group at C7a of the
2,5-dioxotetrahydro-5H-oxazolo[4,3-b]oxazole rigid bicyclic sys-
tem conﬁrmed that C3 displays an R-conﬁguration in compound
5 and an S-conﬁguration in adduct 5′ (Supporting Information).
These structural features were conﬁrmed by X-ray analysis of
compound 5 (Supporting Information). This very same
stereochemical outcome of the S-Michael addition was observed
for the ﬁrst-generation chiral Dhas 2 and ent-2, suggesting
similar stereoselection pathways for both scaﬀolds. However, a
signiﬁcant diﬀerence was observed with respect to our ﬁrst-
generation chiral acrylates (2 and ent-2), that is, the complete
diastereoselectivity for the S-Michael addition observed at −78
°C with 4 is maintained at 25 °C. After diﬀerent concentrations
and bases were explored (Supporting Information), the best
conditions involved dropwise addition of equimolecular amounts
of thiocarbohydrate and the use of THF as a solvent and
triethylamine (TEA) as a base at 25 °C, aﬀording a 99% yield of
adduct 5 with a diastereoselectivity >95:5, on a gram scale
(Scheme 2). The optimal reaction time (5 min) is the time
necessary to slowly add the thiocarbohydrate; therefore, this S-
Michael addition can be regarded as a true click reaction. These
conditions were also tested with Dha 2, aﬀording a poor
diastereoselectivity (Supporting Information).
In order to test the scope of the reaction, chiral Dha 4 was
treated with several thiols (a−h) under similar conditions, the
corresponding conjugate additions providing a wide panel of
post-translational modiﬁcations that are commonly found on
peptides and proteins. In all cases, each of the 1,4-conjugate
adducts (5a−h) was obtained as a unique stereoisomer with high
yield and diastereoselectivity (Scheme 3). The absolute
conﬁguration of the new generated stereocenter was also
determined by NOESY−NMR experiments (Supporting In-
formation). We were delighted to observe that the same
stereochemical outcome was maintained for all S-nucleophiles
with Dha 4, unlike with Dha 2.23a
These results indicate a robust stereoinduction mechanism for
the protonation of the enolate adduct upon conjugate addition in
Dha 4. The calculated structure of a model enolate usingMeS− as
a nucleophile revealed a slight pyramidalization of the enolic
carbon (θ = 8°), suggesting a more favorable protonation by the
concave (Si) face (Figure 1). The steric hindrance exerted by the
bridgehead methyl group at position 7a and the appearance of
torsional strain in the ﬁve-membered oxazolidin-5-one upon
protonation of the enolate by the convex (Re) face25 also favor
protonation by the, in principle, less accessible concave face, as
demonstrated by transition-state (TS) calculations (Supporting
Information).
Complete hydrolysis of 5 and 5′ with aqueous 4 M HCl at 40
°C for 16 h yielded the corresponding S-GalNAc-L- and D-
cysteine hydrochlorides 1 and 1′ in good yields (93−94%,
Scheme 2. Diastereoselective S-Michael Addition of GalNAc-
α-SH to Bicyclic Chiral Dha 4 and ent-4 and Hydrolysis
Scheme 3. S-Michael Addition of Thiols a−g to Dha 4
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Scheme 2). The stereochemical integrity of both the α-carbon
and the α-S-glycosidic bond of these sulfa-Tn antigen derivatives
was maintained upon deprotection, as veriﬁed by their optical
and NMR properties (Supporting Information). Orthogonally
protected versions of these S-glycosylated amino acids are readily
accessible through our previous protocol.23b
Apart from the synthetic advantages of these new bicyclic
Michael acceptors 4 and ent-4 over 2 and ent-2 (highly
stereoselective at noncryogenic temperatures, more reactive
toward both S-Michael addition and subsequent deprotection,
providing cleaner reactions and higher yields), they oﬀer the
attractive feature of their carboxylic acid group being eﬀectively
protected and activated for peptide coupling as an oxazolidin-5-
one. As a proof of concept, we coupled 5 and 5′ with diﬀerent α-
and β-amino ester hydrochlorides (Gly, Ala, Phe, unprotected
Ser and β-Ala) in the presence of sodium 2-ethylhexanoate as a
base in moderate to good yields and without epimerization of the
cysteine α-carbon (Table 1). The acidic hydrolysis of selected
adducts 7b,c and 7b′ with 4 M HCl at 40 °C and subsequent
puriﬁcation by preparative HPLC gave enantiopure S-
glycodipeptides L-Cys(α-D-GalNAc)-β-Ala (8b) L-Cys(α-D-
GalNAc)-L-Phe (8c), and D-Cys(α-D-GalNAc)-β-Ala (8b′) in
good yields (Table 1 and Supporting Information).
In addition, the synthetic versatility of bicycles 4 and ent-4was
further expanded by performing the peptide coupling reactions
before the S-Michael addition step. Thus, bicycles 4 and ent-4
were directly coupled to several α- and β-amino ester
hydrochlorides to provide dehydropeptides 9c and 9a′−d′,
respectively, in moderate yields under the aforementioned
aminolysis conditions (Table 1). Of note, the addition of
GalNAc-α-SH to dehydrodipeptide 9c with TEA as a base at 25
°C yielded protected S-glycodipeptide 7cwith identical complete
diastereoselectivity than described above using the S-Michael/
aminolysis reactions sequence, with a good yield (97%, Scheme
4). To discard the role of the conﬁguration of L-Phe as a
stereodirecting factor in the S-Michael addition of dehydropep-
tide 9cwith GalNAc-α-SH 3, we synthesized the dehydropeptide
9c-D-Phe and carried out the S-Michael addition under the same
conditions obtaining high yield and diastereoselectivity with the
same stereochemical outcome (R) at the cysteine α-carbon
(Supporting Information). Although still under development,
this strategy provides an eﬀective entry to the programmable site-
selective modiﬁcation of dehydropeptides with high diaster-
eoselectivity, a challenge that cannot be accomplished with
classic Dha derivatives.26
In summary, we have developed a new bicyclic chiral
dehydroalanine that behaves as an excellent Michael acceptor
in the stereoselective 1,4-conjugate addition of tri-O-acetyl-2-
acetamido-2-deoxy-1-thio-α-D-galactopyranose in the presence
of DBU or TEA as bases. This type of S-Michael addition
proceeds quickly and at room temperature; therefore it can be
regarded as a click reaction. The Michael adduct was easily
hydrolyzed to obtain the corresponding glycosyl amino acid S-α-
D-GalNAc-L-Cys, a mimic of the Tn antigen (α-D-GalNAc-L-Ser).
The advantage of this synthetic approach over the previously
published work23b consists of an increase of the yield of the 1,4-
conjugate addition and the ability to carry out the hydrolysis of
the Michael adduct in a clean way, avoiding the problems
observed in other cases.23b The oxazolidinone substructure of
this new dehydroalanine allows ring-opening reactions with
other amino acids to obtain S-glycopeptide derivatives in which
the sulfa-Tn antigen is incorporated. This methodology is
Figure 1.Mechanism of the S-Michael addition of methanethiol to ent-4
in the presence of an abbreviated DBU model as a base, calculated with
PCMTHF/M06-2X/6-31+G(d,p). Relative activation barriers (ΔΔG⧧)
are given in kcal mol−1. Only lowest energy structures are shown (other
conformations are available in the Supporting Information).
Table 1. Peptide Coupling through Ring-Opening Aminolysis
of the Oxazolidin-5-one Followed by Hydrolysis
entry
Michael
adduct HCl·H2NR
aminolysis
producta
(yield, %)
S-glycopeptide
(yield, %)a
1 5′ HCl·Gly-OMe 7a′ (84)
2 5′ HCl·β-Ala-OMe 7b′ (48) 8b′ (82)
3 5′ HCl·Phe-OBn 7c′ (69)
4 5′ HCl·Ala-OMe 7d′ (66)
5 5′ HCl·Ser-OMe 7e′ (76)
6 5 HCl·Gly-OMe 7a (75)
7 5 HCl·β-Ala-OMe 7b (76) 8b (82)
8 5 HCl·Phe-OBn 7c (78) 8c (59)
9 ent-4 HCl·Gly-OMe 9a′ (40)
10 ent-4 HCl·β-Ala-OMe 9b′ (28)
11 ent-4 HCl·Phe-OBn 9c′ (37)
12 ent-4 HCl·Ala-OMe 9d′ (22)
13 4 HCl·Phe-OBn 9c (44)
aYields after puriﬁcation by column chromatograpy.
Scheme 4. S-Michael/Aminolysis vs Aminolysis/S-Michael
Reactions on Chiral Dha 4 To Obtain α-S-Glycopeptide 8c
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currently being expanded in our laboratory to obtain longer
glycopeptides of biological relevance.
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